Applied DNA Sciences, Inc. (UDJ.F)
Frankfurt - Frankfurt Delayed Price. Currency in USD
Add to watchlist
At close: 08:59AM CEST
| Previous Close | 4.6600 |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | N/A - N/A |
| 52 Week Range | 4.6600 - 33.2200 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | 0 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREInstitute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
STONY BROOK, NY / ACCESSWIRE / May 13, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion (ÚHKT/IHBT) today announced that an abstract relating ...
Simply Wall St.Applied DNA Sciences Second Quarter 2024 Earnings: Misses Expectations
Applied DNA Sciences ( NASDAQ:APDN ) Second Quarter 2024 Results Key Financial Results Revenue: US$929.6k (down 79...
- ACCESSWIRE
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
STONY BROOK, NY / ACCESSWIRE / May 10, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March ...
© 2024 Yahoo. All rights reserved.